Evidence map›Paper›PMID 32001050›Full record

ArticleAmerican journal of preventive medicine2020

Availability of Safety-net Sexually Transmitted Disease Clinical Services in the U.S., 2018.

Jami S Leichliter, Kari O'Donnell, Kat Kelley, Kendra M Cuffe, Gretchen Weiss, Thomas L Gift

Open access · greenAbstract readMulticenter Study
In one paragraph

Article in American journal of preventive medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Why Are Gonorrhea Case Rates Declining in the United States? A Research Agenda.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026
    Review
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 3 countries.

Jami S LeichliterDivision of STD Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia. Electronic address: jleichliter@cdc.gov.
Kari O'DonnellHIV, STI, & Viral Hepatitis Program, National Association of County and City Health Officials, Washington, District of Columbia.
Kat KelleyHIV, STI, & Viral Hepatitis Program, National Association of County and City Health Officials, Washington, District of Columbia.
Kendra M CuffeDivision of STD Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia.
Gretchen WeissHIV, STI, & Viral Hepatitis Program, National Association of County and City Health Officials, Washington, District of Columbia.
Thomas L GiftDivision of STD Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia.
Centers for Disease Control and Prevention · USNational Association of County and City Health Officials · US

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

introductionSafety-net sexually transmitted disease services can prevent transmission of sexually transmitted disease. This study assesses the availability of safety-net sexually transmitted disease clinical services across the U.S.

methodsA 2018 survey of U.S. local health departments examined the availability of safety-net providers and the availability of specific sexually transmitted disease clinical services, including point-of-care testing and treatment. In 2019, Rao-Scott chi-square tests were used to compare service availability by clinic type (sexually transmitted disease clinic versus other clinics).

resultsA total of 326 local health departments completed the survey (49% response rate). Of respondents, 64.4% reported that a clinic in their jurisdiction provided safety-net sexually transmitted disease services. Having a safety-net clinic that provided sexually transmitted disease services was more common in medium and large jurisdictions. Sexually transmitted disease clinics were the primary provider in 40.5% of jurisdictions. A wide range of specific sexually transmitted disease services was offered at the primary safety-net clinic for sexually transmitted diseases. Most clinics offered human papillomavirus vaccination and appropriate point-of-care treatment for gonorrhea and syphilis. Fewer than one-quarter of clinics offered point-of-care rapid plasma reagin or darkfield microscopy syphilis testing. Compared with other clinics, services more commonly offered at sexually transmitted disease clinics included same-day services, hepatitis B vaccination, rapid plasma reagin testing (syphilis), any point-of-care testing for gonorrhea, point-of-care trichomonas testing, and extragenital chlamydia or gonorrhea testing.

conclusionsOne-third of local health departments reported no safety-net sexually transmitted disease services or were not aware of the services, and availability of specific services varied. Without an expansion of resources, local health departments might explore collaborations with healthcare systems and innovations in testing to expand sexually transmitted disease services.

Indexed as

Family Planning ServicesPoint-of-Care TestingAdultFemaleGonorrheaHumansMalePapillomavirus InfectionsPapillomavirus VaccinesSafety-net ProvidersSexually Transmitted DiseasesSurveys and QuestionnairesUnited StatesPapillomavirus Vaccines

Identifiers

PMID32001050
PMCPMC10088361
OpenAlexW3003362165

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.